Correlation Between Lixte Biotechnology and Navidea Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lixte Biotechnology Holdings and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Lixte Biotechnology and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Navidea Biopharmaceutica.

Diversification Opportunities for Lixte Biotechnology and Navidea Biopharmaceutica

0.0

Correlation Coefficient

Lixte Biotechnology  Navidea Biopharmaceutica

Pay attention - limited upside

The 3 months correlation between Lixte and Navidea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Navidea Biopharmaceutica go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and Navidea Biopharmaceutica

If you would invest  126.00  in Lixte Biotechnology Holdings on May 3, 2025 and sell it today you would earn a total of  271.00  from holding Lixte Biotechnology Holdings or generate 215.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Lixte Biotechnology Holdings  vs.  Navidea Biopharmaceuticals

Lixte Biotechnology

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lixte Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Navidea Biopharmaceutica

Risk-Adjusted Performance

Very Weak

Over the last 90 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Lixte Biotechnology and Navidea Biopharmaceutica

The main advantage of trading using opposite Lixte Biotechnology and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.

The idea behind Lixte Biotechnology Holdings and Navidea Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.